Dergi makalesi Açık Erişim
Akbari, Soheil; Sevinc, Gulben Gurhan; Ersoy, Nevin; Basak, Onur; Kaplan, Kubra; Sevinc, Kenan; Ozel, Erkin; Sengun, Berke; Enustun, Eray; Ozcimen, Burcu; Bagriyanik, Alper; Arslan, Nur; Onder, Tamer Tevfik; Erdal, Esra
{ "@context": "https://schema.org/", "@id": 75351, "@type": "ScholarlyArticle", "creator": [ { "@type": "Person", "name": "Akbari, Soheil" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Sevinc, Gulben Gurhan" }, { "@type": "Person", "affiliation": "Dokuz Eylul Univ, Hlth Sci Inst, Dept Histol & Embryol, TR-35340 Izmir, Turkey", "name": "Ersoy, Nevin" }, { "@type": "Person", "name": "Basak, Onur" }, { "@type": "Person", "name": "Kaplan, Kubra" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Sevinc, Kenan" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Ozel, Erkin" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Sengun, Berke" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Enustun, Eray" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Ozcimen, Burcu" }, { "@type": "Person", "name": "Bagriyanik, Alper" }, { "@type": "Person", "name": "Arslan, Nur" }, { "@type": "Person", "affiliation": "Koc Univ, Fac Med, TR-34450 Istanbul, Turkey", "name": "Onder, Tamer Tevfik" }, { "@type": "Person", "name": "Erdal, Esra" } ], "datePublished": "2019-01-01", "description": "Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. These applications are, however, limited in their capacity to generate functional hepatocytes in a reproducible and efficient manner. Here, we generated and characterized the hepatic organoid (eHEPO) culture system using human induced pluripotent stem cell (iPSC)-derived EpCAM-positive endodermal cells as an intermediate. eHEPOs can be produced within 2 weeks and expanded long term (>16 months) without any loss of differentiation capacity to mature hepatocytes. Starting from patient-specific iPSCs, we modeled citrullinemia type 1, a urea cycle disorder caused by mutations in the argininosuccinate synthetase (ASST) enzyme. The disease-related ammonia accumulation phenotype in eHEPOs could be reversed by the overexpression of the wild-type ASS1 gene, which also indicated that this model is amenable to genetic manipulation. Thus, eHEPOs are excellent unlimited cell sources to generate functional hepatic organoids in a fast and efficient manner.", "headline": "Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling", "identifier": 75351, "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", "license": "http://www.opendefinition.org/licenses/cc-by", "name": "Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling", "url": "https://aperta.ulakbim.gov.tr/record/75351" }
Görüntülenme | 32 |
İndirme | 4 |
Veri hacmi | 1.2 kB |
Tekil görüntülenme | 31 |
Tekil indirme | 4 |